DIRS.INFO The most relevant business & tech news

☆ They took blockbuster drugs for weight loss and diabetes. Now their stomachs are paralyzed
▼ + stars: | 2023-07-25 | by ( Brenda Goodman | ) edition.cnn.com time to read: +19 min

Emily Wright, 38, a teacher in Toronto, started taking Ozempic in 2018. The diabetes drug Ozempic, and its sister drug for weight loss, Wegovy, utilize the same medication, semaglutide. Gastroparesis can have many causes, including diabetes, which is a reason many people are on these drugs in the first place. In more than half of cases of gastroparesis, doctors are unable to find a cause. Until more is known, George said, people need to be open with all their doctors about taking any drugs.

Persons: Joanie Knight, “, I’d, ”, Knight, ” Brenda Allen, I’m, ” Allen, Emily Wright, she’s, Wright, “ I’ve, ” Wright, Ozempic, Emily Wright Allen doesn’t, they’ve, Gastroparesis, Michael Camilleri, Camilleri, liraglutide, ” Camilleri, ’ Joanie Knight, it’s, —, I’ve, let’s, ’ ” Wright, gastroparesis, ” Knight, we’re, there’s, gastroparesis weren’t, “ Gastroparesis, Linda Nguyen, Nguyen, Renuka George, George, ” George, Dr, Michael Champeau, ” Champeau, Sanjay Gupta Organizations: CNN, US Food and Drug Administration, American Society of Anesthesiologists, Novo Nordisk, Mayo Clinic, National Institutes of Health, Diabetes, ”, FDA, Stanford University, American Gastroenterological Association, Medical University of South, CNN Health, Stanford Locations: Angie , Louisiana, Dallas, Toronto, Medical University of South Carolina, Louisiana

☆ People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
▼ + stars: | 2023-06-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

People on diabetes and weight loss drugs such as Novo Nordisk 's Ozempic and Wegovy should stop taking them before having elective surgery to reduce the risk of serious health complications, a prominent group of doctors said. Under the ASA's guidance, people taking GLP-1 drugs on a daily basis should skip treatment on the day of elective surgery. Those taking GLP-1s weekly should stop treatment a week before the scheduled surgery, the group said. Prior to surgery, doctors should consider consulting with an endocrinologist for guidance on patients who take GLP-1s for diabetes. If a patient has none of those symptoms but did not stop using GLP-1s before the surgery, doctors should consider using ultrasound to check if they have a "full stomach."

Persons: Michael Champeau, Champeau, Eli Lilly Organizations: Novo Nordisk, American Society of Anesthesiologists, ASA, Nordisk's Ozempic Locations: Los Angeles , California, People

Search resuls for: "Michael Champeau"

2 mentions found